12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Company News  |  Deals

Advanced Accelerator Applications, Dompe deal

Advanced Accelerator received exclusive, worldwide rights to develop and commercialize Dompe's FabOvar. The iodine-131 labeled humanized mAb fragment is in...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >